Development of a nomogram for predicting hyperkalemia in advanced chronic kidney disease. [PDF]
Ren FailChávez-Iñiguez JS +11 more
europepmc +1 more source
Finerenone in Asian Patients with Type 2 Diabetes Mellitus and Albuminuric Chronic Kidney Disease: From Evidence to Implementation. [PDF]
Diabetes Metab JYamanouchi M, Furuichi K, Wada T.
europepmc +1 more source
Sodium-Glucose Co-Transporter 2 Inhibitors and Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors During Mineralocorticoid Receptor Antagonist Therapy: A Real-World Cohort Study. [PDF]
Pharmacy (Basel)Almalki AH +6 more
europepmc +1 more source
Association of continuity of care with treatment adherence and quality of life in patients with chronic kidney disease and hyperkalemia: A retrospective study. [PDF]
Medicine (Baltimore)Yan Y, Liu J, Liu G.
europepmc +1 more source
Non-steroidal mineralocorticoid receptor antagonists in non-diabetic kidney disease: a narrative review of mechanisms and clinical advances. [PDF]
BMC NephrolLuo F, Hu J, Fang H, Li X, Zhu C, Bao Z.
europepmc +1 more source
Non-albumin proteinuria as a candidate biomarker of treatment response to finerenone in diabetic kidney disease: a real-world cohort study. [PDF]
Front Endocrinol (Lausanne)Choi MS +7 more
europepmc +1 more source
An unusual cause of chronic recurrent vomiting and life-threatening hyperkalemia: primary adrenal insufficiency due to probable bilateral adrenal tuberculosis. [PDF]
IDCasesGaruma MT +4 more
europepmc +1 more source
Delayed Diagnosis of Mild GLUT1 Deficiency Syndrome Caused by an Apparently De Novo SLC2A1 p.(Phe445del) Variant in a Child with a History of Severe Neonatal Hyperkalemia. [PDF]
Children (Basel)Ivančan S +3 more
europepmc +1 more source
Mechanisms for Mineralocorticoid-Driven Age-Related Hypertension: Potential Therapeutic Role of Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors. [PDF]
Circ ResGolec S, Vaidya A, Pitt B, Jaffe IZ.
europepmc +1 more source